WSA
GEVA

Wall Street Associates’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Wall Street Associates’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-12,428
Closed -$1.21M – 375
2015
Q1 		$1.21M Sell
12,428
-300
-2% -$29.3K 0.11% 193
2014
Q4 		$1.18M Buy
+12,728
New +$1.18M 0.11% 187